Fate Therapeutics Receives Regenerative Medicine Advanced GlobeNewswire Nawigacja wpisu Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE) – Yahoo Finance Verve Therapeutics Announces Positive Initial Data from the – GlobeNewswire